While platform players are going super-wide in their offering, some legal AI startups are going the other way and drilling ...

India wants the U.S. to remove all tariffs—both MFN and country-specific—on high and medium-labour-intensive goods. These ...

FY25 adjusted EPS is forecast at €7.36, rising to €9.74 in FY26 and €12.70 in FY27. UCB’s adjusted EBITDA margin is expected to grow from 30% in FY25 to nearly 40% by 2030, driven by Bimzelx and four ...

SmartEsq’s new gen AI offering aims to automate the side letter compiling process and organize provisions to help users ...

India-US trade talks are in the final stage as India pushes for full exemption from the 26% US tariff and duty cuts on key ...

Given that everyone will suffer from these shocks, cooperation to ameliorate them should be a priority, especially for Asia and Europe. Both regions are heavily integrated into the global trading ...

India-U.S. trade talks in Washington reach crucial stage as New Delhi pushes for market access for labour-intensive goods.

Intense trade discussions between India and the US continue for the sixth consecutive day on Tuesday in Washington, as ...

Royalty Pharma is less exposed to MFN drug pricing risks, offering downside protection in a volatile policy environment. See ...